Clinical Trials Browser

Phase 2 × melflufen × Plasma cell × Clear all

NCT03639610 2023-03-10

BRIDGE

Phase 2 Terminated

35 enrolled 33 charts

Multiple Myeloma, Renal Insufficiency

NCT02963493 2022-11-22

HORIZON

Phase 2 Completed

157 enrolled 26 charts 1 FDA

Multiple Myeloma